Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2):week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

摘要：

Background: Effective two-drug regimens could decrease long-term drug exposure and toxicity with HIV-1 antiretroviral therapy (ART). We therefore aimed to evaluate the efficacy and safety of a two-drug regimen compared with a three-drug regimen for the treatment of HIV-1 infection in ART-na?ve adults.

机标关键词：lamivudine、plus、naive、phase、from、with、adults、antiretroviral、disoproxil、dolutegravir

所属期刊栏目：45

分类号：R657.3;R512.62;S857.4

在线出版日期：2023-10-24（万方平台首次上网日期，不代表论文的发表时间）

页数：共1页

页码：1852